Danaher (NYSE:DHR) Stock: Insider Gregory Milosevich Sells 2,100 Shares

Danaher Corporation (NYSE:DHR) EVP Gregory Milosevich sold 2,100 shares of Danaher stock in a transaction on Monday, November 9th. The shares were sold at an average price of $230.62, for a total transaction of $484,302.00. Following the transaction, the executive vice president owned 22,367 shares in the company, valued at $5,158,277.54. The trade was a 8.58% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Danaher Stock Up 0.6%

Danaher stock traded up $1.29 during trading on Tuesday, reaching $236.41. 3,395,945 shares of the company’s stock were exchanged, compared to its average volume of 4,447,668. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The firm has a market cap of $166.32 billion, a price-to-earnings ratio of 38.69, a PEG ratio of 2.95 and a beta of 0.76. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.29 and a current ratio of 1.63. The company’s 50-day moving average is $220.65 and its two-hundred day moving average is $201.57.

Danaher (NYSE:DHR) last released its quarterly earnings data on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, beating the consensus estimate of $1.92 by $0.19. The company had revenue of $6.55 billion for the quarter, compared to analyst estimates of $6.56 billion. Danaher had a return on equity of 11.17% and a net margin of 16.91%. The firm’s revenue was up 8.3% compared to the same quarter last year. During the same period last year, the company posted $1.89 earnings per share. On average, analysts predict that Danaher Corporation will post 8.59 earnings per share for the current year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th were paid a $0.40 dividend. The ex-dividend date was Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. Danaher’s dividend payout ratio (DPR) is 26.19%.

Analyst Upgrades and Downgrades

Several research firms recently commented on DHR. Citigroup boosted their price target on Danaher from $230.00 to $270.00 and gave the stock a “buy” rating in a research report on Thursday, October 22nd. TD Cowen lifted their price objective on shares of Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a research note on Thursday, October 22nd. UBS Group reiterated a “buy” rating and set a $260.00 price objective on shares of Danaher in a research note on Thursday, October 22nd. Robert W. Baird boosted their target price on shares of Danaher from $246.00 to $254.00 and gave the stock an “outperform” rating in a research report on Thursday, October 22nd. Finally, Royal Bank Of Canada upped their target price on shares of Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a research note on Monday, October 5th. Eighteen investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $242.91.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. BlackRock Inc. acquired a new position in shares of Danaher in the 2nd quarter valued at approximately $10,492,520,000. Wellington Management Group LLP boosted its stake in shares of Danaher by 10.4% during the 2nd quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate’s stock valued at $3,108,031,000 after buying an additional 1,542,310 shares during the last quarter. Jupiter Topco LLC acquired a new stake in shares of Danaher during the second quarter worth approximately $1,456,317,000. Generation Investment Management LLP acquired a new stake in shares of Danaher during the second quarter worth approximately $1,287,949,000. Finally, Bank of America Corp DE acquired a new stake in shares of Danaher during the second quarter worth approximately $993,846,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Company Profile

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.